which glp 1 is the safest GLP-1 Agonists: A Comprehensive Overview Comparing Ozempic, Wegovy and Other

The primary outcome was change in HbA1c from randomisation to the end of treatment, secondary outcomes included body weight change

Additionally, we highlight the gaps for further studies in clinical applications of GLP-1 RAs in aging-related diseases

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

In 'Bench to Bedside,' Keval Chandarana and Rachel Batterham examine how two different methods of bariatric surgery highlight the relevance of gut-derived hormones not only in inducing sustained weight loss but also in improving glucose homeostasis

While significant progress has been made, further research is required to develop therapies that can effectively halt or reverse disease progression, ultimately improving the lives of individuals with DN